HK1205450A1 - Medicine comprising combination of general anesthetic drug and hydrogen - Google Patents

Medicine comprising combination of general anesthetic drug and hydrogen

Info

Publication number
HK1205450A1
HK1205450A1 HK15103729.5A HK15103729A HK1205450A1 HK 1205450 A1 HK1205450 A1 HK 1205450A1 HK 15103729 A HK15103729 A HK 15103729A HK 1205450 A1 HK1205450 A1 HK 1205450A1
Authority
HK
Hong Kong
Prior art keywords
medicine
hydrogen
combination
general anesthetic
anesthetic drug
Prior art date
Application number
HK15103729.5A
Other languages
English (en)
Chinese (zh)
Inventor
Tomiei Kazama
Yasushi Satoh
Ryuji Yonamine
Original Assignee
Maruishi Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruishi Pharma filed Critical Maruishi Pharma
Publication of HK1205450A1 publication Critical patent/HK1205450A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/08Ethers or acetals acyclic, e.g. paraformaldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/55171,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15103729.5A 2012-05-31 2015-04-16 Medicine comprising combination of general anesthetic drug and hydrogen HK1205450A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012125535 2012-05-31
PCT/JP2013/065094 WO2013180240A1 (ja) 2012-05-31 2013-05-30 全身麻酔薬と、水素とを組み合わせてなる、医薬

Publications (1)

Publication Number Publication Date
HK1205450A1 true HK1205450A1 (en) 2015-12-18

Family

ID=49673427

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103729.5A HK1205450A1 (en) 2012-05-31 2015-04-16 Medicine comprising combination of general anesthetic drug and hydrogen

Country Status (16)

Country Link
US (1) US20150079197A1 (xx)
EP (1) EP2857026A4 (xx)
JP (1) JP6168420B2 (xx)
KR (1) KR20150018832A (xx)
CN (1) CN104394873A (xx)
AU (1) AU2013268366A1 (xx)
BR (1) BR112014029260A2 (xx)
CA (1) CA2874579A1 (xx)
HK (1) HK1205450A1 (xx)
IL (1) IL235718A0 (xx)
IN (1) IN2014MN02090A (xx)
MX (1) MX2014014543A (xx)
NZ (1) NZ701553A (xx)
RU (1) RU2014152690A (xx)
SG (1) SG11201407489TA (xx)
WO (1) WO2013180240A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6253029B2 (ja) * 2015-01-21 2017-12-27 大陽日酸株式会社 麻酔器用取付キット
US20180338995A1 (en) * 2017-05-23 2018-11-29 Perricone Hydrogen Water Company, Llc Systems and methods for treatments using hydrogen and/or noble gases
US11129848B2 (en) * 2017-08-08 2021-09-28 Perricone Hydrogen Water Company, Llc Medication enhancement using hydrogen
EP3814502A4 (en) * 2018-06-29 2022-10-05 John Mansell COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANESTHESIA-RELATED NEUROTOXICITY
US11123365B2 (en) 2019-11-18 2021-09-21 Perricone Hydrogen Water Company, Llc Compositions comprising palmitoylethanolamide and hydrogen water, and methods thereof
JP7019910B2 (ja) * 2020-07-21 2022-02-16 MiZ株式会社 薬の副作用、薬の副作用に関連する症状、および/または、治療に伴う副作用を予防および/または改善するための組成物
CN117861037A (zh) * 2022-10-11 2024-04-12 上海氢医医疗科技有限公司 氢气吸入治疗自闭症

Also Published As

Publication number Publication date
EP2857026A1 (en) 2015-04-08
CA2874579A1 (en) 2013-12-05
SG11201407489TA (en) 2014-12-30
BR112014029260A2 (pt) 2017-06-27
JP6168420B2 (ja) 2017-07-26
RU2014152690A (ru) 2016-07-20
AU2013268366A1 (en) 2015-03-19
JPWO2013180240A1 (ja) 2016-01-21
CN104394873A (zh) 2015-03-04
IN2014MN02090A (xx) 2015-09-04
NZ701553A (en) 2016-06-24
EP2857026A4 (en) 2015-11-04
MX2014014543A (es) 2015-06-05
IL235718A0 (en) 2015-01-29
WO2013180240A1 (ja) 2013-12-05
US20150079197A1 (en) 2015-03-19
KR20150018832A (ko) 2015-02-24

Similar Documents

Publication Publication Date Title
IL239557B (en) Microarray for providing therapeutic material and methods for use
HK1216105A1 (zh) 治療劑的遞送
HK1213503A1 (zh) 藥物遞送醫療裝置
ZA201405248B (en) Anesthetic compounds and related methods of use
EP2555751A4 (en) MEDICAL DEVICES COMPRISING MEDICAMENTS AND METHODS OF MAKING AND USING THE SAME
HK1205690A1 (en) Pharmaceutical composition and administration thereof
GB201510816D0 (en) Medical tubes and methods of manufacture
SG11201501075RA (en) Medical devices for blood reflux prevention and methods of use
HK1205450A1 (en) Medicine comprising combination of general anesthetic drug and hydrogen
HK1204773A1 (en) Pyrazole derivative and use thereof for medical purposes
HK1184723A1 (en) Needle cannula containing medicament
HK1208830A1 (en) Drug delivery device for the treatment of patients with respiratory diseases
EP2863858A4 (en) PATIENT DISPOSAL SYSTEMS AND METHOD OF USE
EP2930211A4 (en) RESIN COMPOSITION AND MEDICAMENT CONTAINERS THEREFROM
EP2774596A4 (en) MEDICAL EXTENSION INSTRUMENT AND SET OF MEDICAL EXTENSION INSTRUMENTS
HK1203860A1 (en) Puncture device and drug solution administration device
IL232434A0 (en) Medicine for medical treatment and/or improvement of sepsis
EP2898912A4 (en) INSTRUMENT FOR MEDICINE ADMINISTRATION
SI2656843T1 (sl) Estri bendamustina in povezane spojine ter njihova medicinska uporaba
HK1203955A1 (zh) 反式- -癸烯酸衍生物及含有其的藥物
EP2928540A4 (en) THERAPEUTIC CATHETER AND HIGH PRESSURE IMAGING
EP2830552A4 (en) DEVICE FOR RELEASING AN OPHTHALMIC MEDICAMENT AND USE METHOD
PL2852423T3 (pl) System z inhalatora i kapsułki
HK1200101A1 (en) Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them
GB201208199D0 (en) Inhaler and associated capsule chamber